EladZivMD
Internal Medicine • San Francisco, CAAssociate Professor, Medicine, UCSF School of Medicine
Dr. Ziv is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1701 Divisadero Street
San Francisco, CA 94143Phone+1 415-353-7300Fax+1 415-353-7901
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999- University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1998 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Evaluation of multiple breast cancer polygenic risk score panels in women of Latin American heritage.Xiaosong Huang, Paul C Lott, Donglei Hu, Valentina A Zavala, Zoeb N Jamal
Cancer Epidemiology, Biomarkers & Prevention. 2024-12-03 - Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.Matteo Giaccherini, Alyssa I Clay-Gilmour, Romano Liotti, Angelica Macauda, Manuel Gentiluomo
Blood Cancer Journal. 2024-11-11 - Unraveling the genetic landscape of susceptibility to multiple primary cancers.Pooja Middha, Linda Kachuri, Jovia L Nierenberg, Rebecca E Graff, Taylor B Cavazos
Medrxiv. 2024-10-30
Abstracts/Posters
- Germline Variation Predicts Treatment Response in Multiple MyelomaElad Ziv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall SurvivalElad Ziv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
New Study by HBKU's Qatar Computing Research Institute and Sidra Medicine Reveals Genetic Influence on Cancer Immune ResponsivenessFebruary 17th, 2021- Inherited Genetic Variation Plays Role in Immune Response to Cancer TreatmentFebruary 11th, 2021
- Inherited Genetic Variation May Affect the Response to Cancer ImmunotherapyFebruary 10th, 2021
- Join now to see all
Grant Support
- Admixture Mapping For Breast Cancer In LatinasNational Cancer Institute2007–2011
- Breast Cancer, Breast Density &Admixture Among LatinasNational Cancer Institute2004–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
